Beyond Air is a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generator and delivery system (the LungFit® platform) that is capable of generating NO from ambient air. The LungFit® platform can deliver NO either continuously or for a fixed amount of time at various flow rates and has the ability to either titrate dose on demand or maintain a constant dose. Co.'s areas of focus with the LungFit® are persistent pulmonary hypertension of the newborn, community-acquired viral pneumonia including COVID-19, bronchiolitis, nontuberculous mycobacteria lung infection. We show 14 historical shares outstanding datapoints in our XAIR shares outstanding history coverage, used to compute XAIR market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing XAIR market cap history over the course of time is important for investors
interested in comparing XAIR's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of XAIR versus a peer is one thing; comparing
XAIR market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like XAIR can fluctuate over the course of history.
With this page we aim to empower investors researching XAIR by allowing them to research the XAIR market cap history. |
Free XAIR Email Alerts:
Video: The Importance of Market Cap
